Eris Lifesciences Limited — Others, 27-06-2025: Disclosure under SEBI Takeover Regulations

Kaushal Kamleshbhai Shah, promoter of Eris Lifesciences, has declared that the promoter group holds approximately 54.85% equity shares in the company as of March 31, 2025. No new encumbrances have been created on these shares during the financial year beyond those already disclosed. This confirms stable promoter shareholding with no additional pledging or liens, signaling confidence and unchanged promoter stake for shareholders.